0001600132-23-000015.txt : 20230303 0001600132-23-000015.hdr.sgml : 20230303 20230303171855 ACCESSION NUMBER: 0001600132-23-000015 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230303 ITEM INFORMATION: Other Events FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 23705826 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 8-K 1 blph-20230303x8k.htm 8-K
0001600132falseNASDAQ00016001322023-03-032023-03-03

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

​

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 3, 2023

​

Bellerophon Therapeutics, Inc.

(Exact Name of Registrant as Specified in Charter)

​

​

​

​

​

​

Delaware

    

001-36845

    

47-3116175

(State or Other Jurisdiction of Incorporation)

​

(Commission
File Number)

​

(IRS Employer
Identification No.)

​

​

​

​

​

184 Liberty Corner Road, Suite 302
Warren, New Jersey

    

07059

(Address of Principal Executive Offices)

​

(Zip Code)

​

Registrant’s telephone number, including area code: (908) 574-4770

​

(Former Name or Former Address, if Changed Since Last Report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

​

​

​

​

​

​

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Stock, $0.01 par value per share

​

BLPH

​

The Nasdaq Capital Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

​

​

​

​

☐

Emerging growth company

​

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

​

​

​

​

​

​

​

​

Item 8.01. Other Events.

On March 3, 2023, Bellerophon Therapeutics, Inc. (the “Company”) suspended, and is not offering any shares of its common stock pursuant to, the prospectus supplement dated January 19, 2023 relating to the Open Market Sale Agreement, dated as of July 17, 2020 (the “Sales Agreement”), by and between the Company and Jefferies LLC. The Company will not make any sales of common stock pursuant to the Sales Agreement unless and until a new prospectus supplement is filed with the SEC; however, the Sales Agreement remains in full force and effect.

 

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, which is being made only by means of a written prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, nor shall there be any sale of the Company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction..

​

​

​

2

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​

​

​

​

​

​

​

​

​

BELLEROPHON THERAPEUTICS, INC.

​

​

​

​

Date: March 3, 2023

​

By:

/s/ Peter Fernandes

​

​

​

Name: Peter Fernandes
Title: Chief Executive Officer

​

​

​

​

3

 EX-101.SCH 2 blph-20230303.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 blph-20230303_lab.xml EX-101.LAB EX-101.PRE 4 blph-20230303_pre.xml EX-101.PRE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Mar. 03, 2023
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Mar. 03, 2023
Entity File Number 001-36845
Entity Registrant Name Bellerophon Therapeutics, Inc.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 47-3116175
Entity Address, Address Line One 184 Liberty Corner Road, Suite 302
Entity Address, City or Town Warren
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07059
City Area Code 908
Local Phone Number 574-4770
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value per share
Trading Symbol BLPH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001600132
Amendment Flag false
XML 6 blph-20230303x8k_htm.xml IDEA: XBRL DOCUMENT 0001600132 2023-03-03 2023-03-03 0001600132 false NASDAQ 8-K 2023-03-03 Bellerophon Therapeutics, Inc. DE 001-36845 47-3116175 184 Liberty Corner Road, Suite 302 Warren NJ 07059 908 574-4770 false false false false Common Stock, $0.01 par value per share BLPH false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( %F*8U8'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !9BF-6-&AFQ^T K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)OITU1)'1S43PI""XHWL)D=C?8M"$9:??M;>-N%]$'$'+)S)]O MOH&T&!0.D9[C$"BRHW0U^:Y/"L-&')B# DAX(&]2.2?ZN;D;HC<\7^,>@L$/ MLR>0574#GMA8PP868!%6HM"M1861# _QA+>XXL-G[#+,(E!'GGI.4)I:^$"6&!,T:?O MF5F*M_8G,'Q"DY);>FQG$LQR;GYAUJ>'MZ?,GK%JY/ M;'JD^55RBH^!-N(\^;6YN]\^""TKV135&PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?= MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%, M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @ M68IC5JB-J:U>! QQ !@ !X;"]W;W)K%C>F^KQ4!4F$1*FFN5%FG*]O89$ M;4:.[[S?>!:KM;$WW/$PXRN8@?D]FVJ\R MQ1\"-OG!.;-#62CUQ5X\Q"/'LT200&2L!,?#*]Q DE@EY/AG+^I4[[0=#\_? MU>_+P>-@%CR'&Y6\B-BL1\[ 83$L>9&89[7Y /L!=:U>I)*\_,\VN[9AZ+"H MR(U*]YV1(!5R=^1O^T <=O".= CV'8*2>_>BDO*6&SX>:K5AVK9&-7M2#K7L MC7!"VJS,C,:G ON9\:V*"@RR85S&[$X:8;;L0>ZRC5$;N@9?8INZT5[P>B<8 M'!'\Q/4%\SIG+/""SG^[N\A6 0858%#J=?X?(/MKLLB-QN3^W<2ZTPZ;M6W% M7^49CV#D8$GGH%_!&?_PG=_S?B;(.Q5YAU*OR>?;#)K@Z.Z#\X\$1%A!A*=! M3$$+92,8,RR41AY:J4QLF=FVU'8KMBZIN,_FO4B /17I G03%:WA>?YYIS<( MNP1/K^+IG<+S#"MA2PJ#]L33QDC1.NAU"6B5K;$\YVO0/(/"B"@_P\*-+@C0 M?@7:/P44U93.E"XGPAF;&$82#BG!P"N&U8\QJP4 K/2\0("V_=JM_:^"?S&7F'*YVK3[-6TW O7 M&B1%=K".^-]$5E7C5*M7(:/&F+9H/OU*H=4KB$_:_%=H4Y4;GK _179TBK0H M>GVO>TFQU6N$3[M\F< )?D\=1Z$%+KT!!5*O$SYM[X\JPIA,T;,H,VX1Z?;# M\[#?]RBB>G7P:6M_T<(8D!B8-"WDWC_R1BI::,F3'"BD>H'P:6>?J41$P@BY M8I^PO+7@22,/K=+*4Z\#/NW54PWG$88'<'[M/C5 QF@]GY?+(_FC]5K):O_W M:;O^BNPASPLD:P6D95L!ZQ7 IPU[+@Q^=J@E\X,?%S^Q&40%UMNVD8E6LO6) M"]O,J.C+&?O>N_!\EG'-7GE2 ,MPM/F::XHZJ/T_H U[KGELJV^V31>JL?9: M!*X?IQ\HDMKO ]J;WP/&[MZB-9F6C M] LJF+4UD(S+QM2V"+:56U#[?$#;]![M!J>"1I]]P%GPQCY",Q0MY>$W;P__ M.M0G15 ;?T![]@2G9UQ.T?N$KQIY:(&C07(/MJ5VBX\["$Q+SA)8HI!WT4?; MUKM=\^["J*S;H&CGYA&^#SI5+F_<)N?JO?+L;_ E!+ P04 M" !9BF-6GZ ;\+$" #B# #0 'AL+W-T>6QEO%DN7/ZZZ>S;"=I=67=A['-HN6/O.-%Q[I#)6,>=56R=M8SDK M6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9) ML;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K XU7=>&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2 MVSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK= M5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>6 M5Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEU MXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z M6PEY7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$// M\A=>BD[E\ZI[J,NXZBQ_AOMHD\%G'!QR>(W?# M$T%^@2O&+(=/EB>N$_N MG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"= MXI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C% M^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ; 4/2='@//GL?)=-[*CG_ M5U/\!%!+ P04 " !9BF-6EXJ[', 3 @ "P %]R96QS+RYR96QS MG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2 MW!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N M&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,E MC'%BM/XU@LD/['X 4$L#!!0 ( %F*8U8<.&7J/P$ #P" / >&PO M=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y $U"+5$2XE#Z0JA:5BON2=8C%/B*O M RU?7R=15*1>>O)Z;(UG9A?G2,=]C$?UY5U(A:Z9FWF6I;(&;])-;"#(I(KD M#4M+ARPU!,:F&H"]RZ9Y/LN\P:"7BY%K0]EU$QE*QA@$[( =PCG]SKM6G3#A M'AWR=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\Q,#&;4N*SA5Z,@QV0(SE'WC;B?PT M^]0C;/8?1H04>I8+8864N-_H^8UH/($L#UW+\0D= ZT,PS/%ML%PZ&C$179E MH\]AK$.(<_I/C+&JL(15+%L/@8<<"5PG,*0:FZ15,!X*/:XH$ZQZ#"PAJ748 MJ&2WEYIK=WDWM) MJ'7N0;#W\!J-'[IFBG#S^0W1UW6E\./VR M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/ M3K3G>1,)KM\,<'AT_@%02P,$% @ 68IC5F60>9(9 0 SP, M !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V + M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5 M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T.EY&TWP M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:> M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/] M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4 M" !9BF-6!T%-8H$ "Q $ @ $ 9&]C4')O<',O M87!P+GAM;%!+ 0(4 Q0 ( %F*8U8T:&;'[0 "L" 1 M " :\ !D;V-0&UL M4$L! A0#% @ 68IC5JB-J:U>! QQ !@ ("!# @ M 'AL+W=O7!E&UL4$L%!@ ) D /@( 4 ! $! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 22 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName - blph-20230303x8k.htm 9 blph-20230303x8k.htm blph-20230303.xsd blph-20230303_lab.xml blph-20230303_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "blph-20230303x8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "blph-20230303x8k.htm" ] }, "labelLink": { "local": [ "blph-20230303_lab.xml" ] }, "presentationLink": { "local": [ "blph-20230303_pre.xml" ] }, "schema": { "local": [ "blph-20230303.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "blph", "nsuri": "http://www.bellerophon.com/20230303", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "blph-20230303x8k.htm", "contextRef": "Duration_3_3_2023_To_3_3_2023_o6AGv4VmdkmliLwRE76lOw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "blph-20230303x8k.htm", "contextRef": "Duration_3_3_2023_To_3_3_2023_o6AGv4VmdkmliLwRE76lOw", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bellerophon.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001600132-23-000015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001600132-23-000015-xbrl.zip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end